Direxion Daily Healthcare Bull 3x Shares Rating $69.31 +1.74 (+2.58%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsSEC FilingsShort InterestBuy This Stock Direxion Daily Healthcare Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CURE Aggregate RatingModerate Buy 2.68Holdings in CURE have an aggregate rating of Moderate Buy based on 458 analyst ratings issued in the past year covering 22 companies (63.5% of the portfolio).CURE Aggregate Price Target$69.31High Prediction$69.31Average Prediction$69.31Low Prediction$69.31Holdings in CURE have an aggregate price target of $69.31 and a range of $69.31 to $69.31 covering 22 companies (63.5% of the portfolio).CURE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Healthcare Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 CURE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.06%LLYEli Lilly and Company$625.15-2.5%4.9993 of 5 stars2.68$990.89 58.5%22Trending NewsEarnings ReportAnalyst DowngradeInsider TradeGap UpHigh Trading Volume6.48%JNJJohnson & Johnson$173.40+1.1%4.6862 of 5 stars2.65$174.50 0.6%20Positive News5.35%ABBVAbbVie$198.10-0.4%4.6817 of 5 stars2.93$214.43 8.2%27Trending NewsAnalyst UpgradeInsider Trade4.01%UNHUnitedHealth Group$250.74+2.5%4.9963 of 5 stars2.50$366.52 46.2%24Trending NewsAnalyst Forecast3.47%ABTAbbott Laboratories$134.41+1.8%4.9082 of 5 stars2.91$144.47 7.5%22Positive News3.35%MRKMerck & Co., Inc.$80.73+0.4%4.9933 of 5 stars2.35$107.44 33.1%20Positive News2.85%TMOThermo Fisher Scientific$461.34+1.5%4.9919 of 5 stars2.71$593.00 28.5%21Positive NewsInsider Trade2.78%ISRGIntuitive Surgical$470.08+0.1%4.9304 of 5 stars2.63$595.95 26.8%19Positive News2.63%AMGNAmgen$288.23+1.2%4.5751 of 5 stars2.33$303.76 5.4%21Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision2.49%BSXBoston Scientific$103.22+0.3%4.5558 of 5 stars3.04$117.50 13.8%26Positive News2.29%PFEPfizer$24.57+1.4%4.9859 of 5 stars2.39$28.12 14.4%18Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.24%GILDGilead Sciences$119.41+8.3%4.6521 of 5 stars2.85$114.82 -3.8%26Trending NewsEarnings ReportDividend AnnouncementAnalyst UpgradeGap UpHigh Trading Volume2.17%SYKStryker$377.73+0.4%4.9238 of 5 stars2.79$430.10 13.9%19Trending NewsDividend AnnouncementInsider Trade2.05%DHRDanaher$200.70+1.1%4.849 of 5 stars2.85$247.61 23.4%20Positive News1.93%VRTXVertex Pharmaceuticals$366.54-2.4%4.8593 of 5 stars2.56$497.10 35.6%27Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst Revision1.88%MDTMedtronic$92.94+1.9%4.6142 of 5 stars2.59$98.19 5.6%22Positive News1.58%BMYBristol Myers Squibb$45.96+1.3%4.6232 of 5 stars2.24$56.38 22.7%21Positive NewsAnalyst Downgrade1.41%MCKMcKesson$667.14+0.6%4.5017 of 5 stars2.86$718.73 7.7%14Positive NewsEarnings ReportAnalyst ForecastAnalyst Revision1.25%CICigna Group$275.03+1.5%5 of 5 stars3.00$377.72 37.3%20Analyst Forecast1.18%CVSCVS Health$65.49+3.0%4.9985 of 5 stars2.90$75.39 15.1%21Positive News1.08%ZTSZoetis$147.34-0.6%4.8053 of 5 stars2.70$204.63 38.9%10Positive NewsEarnings ReportAnalyst Revision1.01%ELVElevance Health$294.33+3.8%4.9371 of 5 stars2.67$418.19 42.1%18Positive News This page (NYSEARCA:CURE) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Healthcare Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Healthcare Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CURE Stock Alerts